VCM
FTXH icon

Vivaldi Capital Management’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Vivaldi Capital Management’s Portfolio FTXH Stock Details FTXH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Buy
12,590
+1,741
+16% +$59.5K 0.06% 175
2025
Q4 		$357K Buy
10,849
+1,059
+11% +$33K 0.05% 195
2025
Q3 		$279K Buy
9,790
+384
+4% +$10.4K 0.04% 227
2025
Q2 		$241K Sell
9,406
-1,714
-15% -$43.4K 0.04% 256
2025
Q1 		$306K Buy
11,120
+2,443
+28% +$67.7K 0.05% 204
2024
Q4 		$243K Buy
8,677
+1,171
+16% +$32.9K 0.04% 238
2024
Q3 		$216K Sell
7,506
-541
-7% -$15.5K 0.06% 205
2024
Q2 		$219K Sell
8,047
-492
-6% -$13.2K 0.06% 208
2024
Q1 		$229K Buy
+8,539
New +$235K 0.07% 201

Other funds holding FTXH

LPL Financial
LPL Financial San Diego, California $376B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.1B AUM 21.09% 1-Year Est. Return
MIM
Marshall Investment Management Littleton, Colorado $208M AUM 30.96% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
AIP
Ameritas Investment Partners Lincoln, Nebraska $3.25B AUM 28.52% 1-Year Est. Return
NP
Nilsine Partners Greenwood Village, Colorado $1.28B AUM 27.63% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return